NAD+ and Sleep Apnea: What the Muscle-Metabolism Research Actually Shows

Written by the Nuvirox Research Team

Short answer: no. No published clinical trial has tested NAD+, NR, or NMN as a treatment for obstructive sleep apnea, and nothing in the current evidence suggests a NAD+ supplement will change how many times you stop breathing at night. What does exist is a more narrow, mechanistic thread of research connecting NAD+ metabolism to the health of the muscles that hold your upper airway open — interesting biology, but a long way from a treatment claim.

Why would NAD+ even come up in a conversation about sleep apnea?

Obstructive sleep apnea happens when the muscles supporting the soft tissue in your throat relax too much during sleep, letting the airway collapse or narrow. Researchers studying why this happens more often in people with obesity have looked at whether the dilator muscles that are supposed to keep the airway open are working properly at the metabolic level — and that is where NAD+ enters the picture, because NAD+ is required for basic muscle energy metabolism.

What did the 2025 airway-muscle study actually find?

A study published in 2025 looked at NAMPT, the enzyme that controls the rate-limiting step of NAD+ production in cells. Elevated NAMPT has been reported in people with obesity, and researchers wanted to know whether it was involved in the upper airway muscle problems seen in obesity-related OSA. Using electrical impedance myography and polysomnography in 110 participants — 70 with moderate-to-severe OSA and 40 with mild or no OSA — the researchers linked NAMPT acetylation to muscle dysfunction associated with more severe apnea.

That is a real finding, but it is a correlation observed in people who already have OSA of varying severity, not a test of whether changing NAD+ levels changes outcomes. It tells you the biology is connected; it does not tell you that taking an NAD+ precursor would help.

Is anyone actually testing NAD+ supplements for sleep, and does that include apnea patients?

Yes and no. A trial called NADream is currently testing whether NAD+ supplementation (in the NR form) improves sleep quality in healthy adults aged 40 to 60. But its exclusion criteria are telling: people with sleep-related breathing disorders, defined as an apnea-hypopnea index of 5 or higher, are explicitly excluded from participating. In other words, the most directly relevant ongoing human research into NAD+ and sleep quality was deliberately designed to exclude people with sleep apnea — which underscores how far the current science is from supporting an apnea-specific claim.

What human studies actually show

The airway-muscle correlation study (2025, cross-sectional, n=110). Participants with moderate-to-severe OSA showed patterns of NAMPT acetylation associated with impaired upper airway dilator muscle function compared to those with mild or no OSA. This is observational: it establishes an association in people who already have the condition, not a before-and-after effect of raising NAD+.

The closest thing to an interventional data point: a 2025 long-COVID trial (n=58, 24 weeks, NR 2000 mg/day). This randomized, placebo-controlled trial measured sleep quality as one of several secondary outcomes in people with long-COVID (not OSA). The honest result: NR raised NAD+ levels within 5 weeks but did not significantly improve sleep, fatigue, cognition, or mood compared to placebo over the main study period, though exploratory within-group analysis suggested some benefit after 10 weeks. This population did not have diagnosed sleep apnea, so it cannot answer the OSA question directly — but it is a useful reminder that raising NAD+ has not reliably translated into better subjective sleep even in trials designed to look for it.

The null result that matters most: there is no OSA-specific trial to cite. A search of the clinical trial literature turns up mechanistic and observational work, plus one ongoing healthy-adult sleep trial that specifically excludes people with OSA. That absence is itself the honest finding here.

What NAD+ supplementation won’t do for sleep apnea

Sleep apnea is a mechanical and neuromuscular problem: the airway physically narrows or collapses. The proven treatments — CPAP or other positive airway pressure therapy, weight management, oral appliances, positional therapy, and in select cases surgery — work by keeping the airway open or reducing the tissue that collapses it. Nothing about raising cellular NAD+ levels has been shown to change airway collapsibility, apnea-hypopnea index, or oxygen desaturation.

If you snore heavily, wake up gasping, or feel excessively sleepy during the day despite adequate time in bed, that warrants a conversation with a doctor and, likely, a sleep study — not a supplement in place of one. Untreated OSA is linked to elevated cardiovascular risk, and a NAD+ precursor is not a substitute for diagnosis or treatment.

If you’re already using NAD+ precursors for other reasons

Human trials of NR in unrelated conditions have used doses from 250 mg to 2,000 mg per day, generally well tolerated. There is no OSA-specific dose because there is no OSA-specific trial. If you take NAD+ Restore for general cellular energy support while also managing OSA with CPAP or another prescribed treatment, there is no known interaction reported in the literature — but this is not something to substitute for your apnea treatment.

Frequently asked questions

Can NAD+ supplements treat sleep apnea?

No. No clinical trial has tested NAD+ precursors as an OSA treatment, and the mechanical nature of the condition means a supplement is unlikely to substitute for CPAP, weight management, or other validated therapies.

Why do people connect NAD+ with sleep apnea at all?

Because researchers have found that an enzyme controlling NAD+ production (NAMPT) behaves differently in the airway muscles of people with more severe OSA related to obesity. That’s a metabolic correlation, not evidence that supplementing NAD+ changes the condition.

Could an NAD+ supplement help with the daytime fatigue that comes with sleep apnea?

That’s a separate question from treating the apnea itself. Fatigue from OSA is best addressed by treating the underlying breathing disruption — see our review of NAD+ and daytime energy for that separate question. Whether general cellular energy support offers anything on top of that hasn’t been tested in this population.

Is it safe to take NAD+ Restore while using CPAP?

There’s no documented interaction between NAD+ precursors and CPAP therapy in the literature. Still, talk to your doctor before adding any supplement, particularly given the cardiovascular risk factors common in people with OSA.

The bottom line

The link between NAD+ and sleep apnea is real biology — airway muscle metabolism appears to be part of the OSA picture in obesity — but it has not been translated into anything resembling a treatment. If you have or suspect sleep apnea, the evidence-backed path runs through a sleep study and CPAP or another prescribed therapy, not a supplement bottle.

References

1. Xu W, et al. Nicotinamide Phosphoribosyltransferase Acetylation Mediating Muscle Dysfunction Contributes to Sleep Apnoea in Obesity. 2025. PMC11790607.
2. NADream: Effects of Nicotinamide Adenine Dinucleotide Supplementation on Sleep Quality in Healthy Individuals. ClinicalTrials.gov NCT06971224.
3. Wu CY, Reynolds WC, Abril I, et al. Effects of nicotinamide riboside on NAD levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial. eClinicalMedicine. 2025;89:103633. doi:10.1016/j.eclinm.2025.103633.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.